AREV Nanotec Receives First Shipment of its NaturVac Product


VANCOUVER, BC – TheNewswire - December 24, 2020 - AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV Brands”) is pleased to announce that it has received its’ first trial run of its NaturVac Immune Boost.


NaturVac is the company’s proprietary blended Sea Cucumber, Turmeric and Astaxanthin (known to Decrease oxidative stress on the heart and blood vessels), Vitamin D3  (known to help to maintain immune function)  Zinc, (known to help to maintain immune function) and B12 (known to help to form red blood cells).


Sea cucumbers are rich in protein, Chondroitin sulphate niacin, and riboflavin and contain substances thought to influence human health, including: Coelomic fluid (a compound that functions similarly to white blood cells in humans), Palmitic, stearic, and linoleic acid (fatty acids with potent antioxidant effects), Squalene (a compound that acts the precursor to steroids) and Triterpenoids (a class of compounds thought to slow cancer growth).


Naturvac has been formulated to provide pre-emptive approach to maintaining a healthy immune system. The trial run will be marketed under the company’s “BARE - People” Brand.


Mr. Withrow stated “We have been working on the optimal extraction method to sperate oils from the sea cucumber  powder. Using our proprietary methods we are able to use and market the powder in our Bare people and Bare pet and vet lines.” He went on to say, “ We plan to position the sea cucumber oil as an alternative krill oil and curcumin markets as an anti-inflammatory. On behalf of management at AREV brands and our laboratory team, we wish all stakeholders a safe and Happy Holiday season and wish you the best after what has been an extraordinary year. Our lab will be hard at work through the holidays, in to 2021 and beyond to bring new ethically sourced, plant-based, functional alternative medicines and innovative products to market utilizing our infrastructure, team, knowhow and long standing distribution relationships. We thank you again for your support Happy Holidays..”


The company has also issued 300,000 stock options to Directors, Officers and Consultants of the Company at a price of $0.17 for a period of 5 years from the issuance dated. These options will vest immediately.


For further information, contact Mike Withrow, 778-929-6536.


On behalf of the Board,


Mike Withrow
CEO & Director

About AREV NanoTec Inc.  
AREV NanoTec Brands Inc. (“AREV”) produces and sells functional ingredients produced via its proprietary extraction systems. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition markets. AREV’s model is to toll process extraction of targeted essential and functional oils and license its formulations to Licensed Producers in Canada.  The company utilizes toll processors in foreign countries to encapsulate and package its formulations that can be sold in traditional distribution channels and online.





Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, and continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements.  Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on   

Copyright (c) 2020 TheNewswire - All rights reserved.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.